Global Plasma Derived Medicine Market Research Report 2024(Status and Outlook)

Global Plasma Derived Medicine Market Research Report 2024(Status and Outlook)



Report Overview:

Plasma Derived Medicine is any therapeutic substance prepared from human blood.

The Global Plasma Derived Medicine Market Size was estimated at USD 2456.59 million in 2023 and is projected to reach USD 3855.18 million by 2029, exhibiting a CAGR of 7.80% during the forecast period.

This report provides a deep insight into the global Plasma Derived Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma Derived Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma Derived Medicine market in any manner.

Global Plasma Derived Medicine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

Shanghai RAAS

China Biologic Products

Hualan Biological Engineering Inc.

Beijing Tiantan Biological Products Corp

Pacific Shuanglin

Boya Bio-Pharmaceutical

Paisi Feike Biology Pharmacy Co., Ltd.

Xinjiang Deyuan Bioengineering

Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

Shenzhen Weiguang

Shanxi Kangbao

Nanyue Biopharming Corporation Ltd

Market Segmentation (by Type)

Albumin

Immune Globulin

Coagulation Factor

Others

Market Segmentation (by Application)

Bleeding Wound

Immunodeficiency

HBV

Tetanus

Rabies

Hemophilia

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Plasma Derived Medicine Market

Overview of the regional outlook of the Plasma Derived Medicine Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma Derived Medicine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Plasma Derived Medicine
1.2 Key Market Segments
1.2.1 Plasma Derived Medicine Segment by Type
1.2.2 Plasma Derived Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Plasma Derived Medicine Market Overview
2.1 Global Market Overview
2.1.1 Global Plasma Derived Medicine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Plasma Derived Medicine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Plasma Derived Medicine Market Competitive Landscape
3.1 Global Plasma Derived Medicine Sales by Manufacturers (2019-2024)
3.2 Global Plasma Derived Medicine Revenue Market Share by Manufacturers (2019-2024)
3.3 Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Plasma Derived Medicine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Plasma Derived Medicine Sales Sites, Area Served, Product Type
3.6 Plasma Derived Medicine Market Competitive Situation and Trends
3.6.1 Plasma Derived Medicine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Plasma Derived Medicine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Plasma Derived Medicine Industry Chain Analysis
4.1 Plasma Derived Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Plasma Derived Medicine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Plasma Derived Medicine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma Derived Medicine Sales Market Share by Type (2019-2024)
6.3 Global Plasma Derived Medicine Market Size Market Share by Type (2019-2024)
6.4 Global Plasma Derived Medicine Price by Type (2019-2024)
7 Plasma Derived Medicine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma Derived Medicine Market Sales by Application (2019-2024)
7.3 Global Plasma Derived Medicine Market Size (M USD) by Application (2019-2024)
7.4 Global Plasma Derived Medicine Sales Growth Rate by Application (2019-2024)
8 Plasma Derived Medicine Market Segmentation by Region
8.1 Global Plasma Derived Medicine Sales by Region
8.1.1 Global Plasma Derived Medicine Sales by Region
8.1.2 Global Plasma Derived Medicine Sales Market Share by Region
8.2 North America
8.2.1 North America Plasma Derived Medicine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Plasma Derived Medicine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Plasma Derived Medicine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Plasma Derived Medicine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Plasma Derived Medicine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Takeda
9.1.1 Takeda Plasma Derived Medicine Basic Information
9.1.2 Takeda Plasma Derived Medicine Product Overview
9.1.3 Takeda Plasma Derived Medicine Product Market Performance
9.1.4 Takeda Business Overview
9.1.5 Takeda Plasma Derived Medicine SWOT Analysis
9.1.6 Takeda Recent Developments
9.2 CSL
9.2.1 CSL Plasma Derived Medicine Basic Information
9.2.2 CSL Plasma Derived Medicine Product Overview
9.2.3 CSL Plasma Derived Medicine Product Market Performance
9.2.4 CSL Business Overview
9.2.5 CSL Plasma Derived Medicine SWOT Analysis
9.2.6 CSL Recent Developments
9.3 Grifols
9.3.1 Grifols Plasma Derived Medicine Basic Information
9.3.2 Grifols Plasma Derived Medicine Product Overview
9.3.3 Grifols Plasma Derived Medicine Product Market Performance
9.3.4 Grifols Plasma Derived Medicine SWOT Analysis
9.3.5 Grifols Business Overview
9.3.6 Grifols Recent Developments
9.4 Octapharma
9.4.1 Octapharma Plasma Derived Medicine Basic Information
9.4.2 Octapharma Plasma Derived Medicine Product Overview
9.4.3 Octapharma Plasma Derived Medicine Product Market Performance
9.4.4 Octapharma Business Overview
9.4.5 Octapharma Recent Developments
9.5 Kedrion
9.5.1 Kedrion Plasma Derived Medicine Basic Information
9.5.2 Kedrion Plasma Derived Medicine Product Overview
9.5.3 Kedrion Plasma Derived Medicine Product Market Performance
9.5.4 Kedrion Business Overview
9.5.5 Kedrion Recent Developments
9.6 LFB Group
9.6.1 LFB Group Plasma Derived Medicine Basic Information
9.6.2 LFB Group Plasma Derived Medicine Product Overview
9.6.3 LFB Group Plasma Derived Medicine Product Market Performance
9.6.4 LFB Group Business Overview
9.6.5 LFB Group Recent Developments
9.7 Biotest
9.7.1 Biotest Plasma Derived Medicine Basic Information
9.7.2 Biotest Plasma Derived Medicine Product Overview
9.7.3 Biotest Plasma Derived Medicine Product Market Performance
9.7.4 Biotest Business Overview
9.7.5 Biotest Recent Developments
9.8 BPL
9.8.1 BPL Plasma Derived Medicine Basic Information
9.8.2 BPL Plasma Derived Medicine Product Overview
9.8.3 BPL Plasma Derived Medicine Product Market Performance
9.8.4 BPL Business Overview
9.8.5 BPL Recent Developments
9.9 Shanghai RAAS
9.9.1 Shanghai RAAS Plasma Derived Medicine Basic Information
9.9.2 Shanghai RAAS Plasma Derived Medicine Product Overview
9.9.3 Shanghai RAAS Plasma Derived Medicine Product Market Performance
9.9.4 Shanghai RAAS Business Overview
9.9.5 Shanghai RAAS Recent Developments
9.10 China Biologic Products
9.10.1 China Biologic Products Plasma Derived Medicine Basic Information
9.10.2 China Biologic Products Plasma Derived Medicine Product Overview
9.10.3 China Biologic Products Plasma Derived Medicine Product Market Performance
9.10.4 China Biologic Products Business Overview
9.10.5 China Biologic Products Recent Developments
9.11 Hualan Biological Engineering Inc.
9.11.1 Hualan Biological Engineering Inc. Plasma Derived Medicine Basic Information
9.11.2 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Overview
9.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Product Market Performance
9.11.4 Hualan Biological Engineering Inc. Business Overview
9.11.5 Hualan Biological Engineering Inc. Recent Developments
9.12 Beijing Tiantan Biological Products Corp
9.12.1 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Basic Information
9.12.2 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Overview
9.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Market Performance
9.12.4 Beijing Tiantan Biological Products Corp Business Overview
9.12.5 Beijing Tiantan Biological Products Corp Recent Developments
9.13 Pacific Shuanglin
9.13.1 Pacific Shuanglin Plasma Derived Medicine Basic Information
9.13.2 Pacific Shuanglin Plasma Derived Medicine Product Overview
9.13.3 Pacific Shuanglin Plasma Derived Medicine Product Market Performance
9.13.4 Pacific Shuanglin Business Overview
9.13.5 Pacific Shuanglin Recent Developments
9.14 Boya Bio-Pharmaceutical
9.14.1 Boya Bio-Pharmaceutical Plasma Derived Medicine Basic Information
9.14.2 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Overview
9.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Product Market Performance
9.14.4 Boya Bio-Pharmaceutical Business Overview
9.14.5 Boya Bio-Pharmaceutical Recent Developments
9.15 Paisi Feike Biology Pharmacy Co., Ltd.
9.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Basic Information
9.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Overview
9.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Market Performance
9.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Business Overview
9.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
9.16 Xinjiang Deyuan Bioengineering
9.16.1 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Basic Information
9.16.2 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Overview
9.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Market Performance
9.16.4 Xinjiang Deyuan Bioengineering Business Overview
9.16.5 Xinjiang Deyuan Bioengineering Recent Developments
9.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
9.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Basic Information
9.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Overview
9.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Market Performance
9.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Business Overview
9.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
9.18 Shenzhen Weiguang
9.18.1 Shenzhen Weiguang Plasma Derived Medicine Basic Information
9.18.2 Shenzhen Weiguang Plasma Derived Medicine Product Overview
9.18.3 Shenzhen Weiguang Plasma Derived Medicine Product Market Performance
9.18.4 Shenzhen Weiguang Business Overview
9.18.5 Shenzhen Weiguang Recent Developments
9.19 Shanxi Kangbao
9.19.1 Shanxi Kangbao Plasma Derived Medicine Basic Information
9.19.2 Shanxi Kangbao Plasma Derived Medicine Product Overview
9.19.3 Shanxi Kangbao Plasma Derived Medicine Product Market Performance
9.19.4 Shanxi Kangbao Business Overview
9.19.5 Shanxi Kangbao Recent Developments
9.20 Nanyue Biopharming Corporation Ltd
9.20.1 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Basic Information
9.20.2 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Overview
9.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Market Performance
9.20.4 Nanyue Biopharming Corporation Ltd Business Overview
9.20.5 Nanyue Biopharming Corporation Ltd Recent Developments
10 Plasma Derived Medicine Market Forecast by Region
10.1 Global Plasma Derived Medicine Market Size Forecast
10.2 Global Plasma Derived Medicine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Plasma Derived Medicine Market Size Forecast by Country
10.2.3 Asia Pacific Plasma Derived Medicine Market Size Forecast by Region
10.2.4 South America Plasma Derived Medicine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Plasma Derived Medicine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Plasma Derived Medicine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Plasma Derived Medicine by Type (2025-2030)
11.1.2 Global Plasma Derived Medicine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Plasma Derived Medicine by Type (2025-2030)
11.2 Global Plasma Derived Medicine Market Forecast by Application (2025-2030)
11.2.1 Global Plasma Derived Medicine Sales (Kilotons) Forecast by Application
11.2.2 Global Plasma Derived Medicine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings